Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nerve Flow Labs is a US-based dietary supplement company that manufactures and markets NerveFlow, an over-the-counter natural supplement designed to support nerve health, alleviate neuropathy symptoms, and reduce nerve pain. The product is formulated with a blend of vitamins and botanical extracts, including Vitamin B complex, garlic powder, hawthorn berry extract, and olive leaf extract, which are claimed to promote healthy circulation and reduce nerve inflammation. Despite its marketing claims of promoting nerve regeneration and cellular-level repair, the supplement is not FDA-approved, and its efficacy has not been validated by peer-reviewed clinical trials. The company operates primarily through online direct-to-consumer sales and has faced scrutiny regarding its marketing practices and customer billing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nerve Flow Labs.